CLINICAL_TRIALS trial_result · 2025-06-03

Clinical Trial Update: Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension [Phase 3]

Phase 3 trial results comparing GMRx2 to placebo for hypertension were completed and posted on 2025-06-03, reporting on efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: George Medicines PTY Limited | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2025-06-03